☰

Global Continuous Glucose Monitoring (CGM) Sensors Market

Report ID : 1181 | Published : 2022-08-16 | Pages: 190 | Format: PDF/EXCEL

Share

The global Continuous Glucose Monitoring (CGM) Sensors market size was accounted at USD 3.6 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 18% from 2022 to 2030. Diabetes technology has progressed remarkably over the past few years, including the development of markers for diabetes control, sophisticated monitoring techniques, mathematical models, assessment procedures, and control algorithms. Continuous glucose monitoring (CGM) sensors provide an effective approach in diabetes management as it checks glucose levels in real-time, displays the change in glucose levels. It also can be used as a tool to predict impending glucose excursions and to assess glycaemic variability. The clinical use of CGM also lowers the risk of mild to moderate hypoglycemia and eradicates the risk of severe and prolonged hypoglycemia.

These devices can be segregated as totally invasive, minimally invasive, and noninvasive based on the nature of their operation. Currently, automation of glucose monitoring is anticipated to save significant nursing time while improving glucose control and safety.

The Global Continuous Glucose Monitoring (CGM) Sensors market is expected to be driven mainly by the growing prevalence of Type 1 and Type 2 diabetes along with the growing geriatric population over the forecast period.

Furthermore, rapidly shifting consumer predilections toward an effective approach to manage diabetes, robust adoption of advanced diabetes management solutions in developing regions, favorable government policies, and rising healthcare spending over time across the globe, growing health awareness, increasing medical tourism, and easy affordability are key factors that are projected to further aid the market growth during the forecast period.

The Global Continuous Glucose Monitoring (CGM) Sensors Market is categorized on the basis of products, sensing technology, end-users, patient population, sites, and region.

On the basis of products, the market is segmented into non-invasive sensing and minimally invasive sensing. Based on sensing technology, the market is segmented into enzyme electrode, optical fluorescence, and others. On the basis of end-users, the market is segregated into hospitals and home care, specialty clinics, ambulatory settings, and others. On the basis of patient population, the market is segmented into children & teenagers, and adults.  Based on sensor sites, the market is categorized into abdomen, upper arm (implanted), back of upper arm, and other (abdomen and buttocks). Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.

The key players of this market include Medtronics, Dexcom, Senseonics, WaveForm Technologies, Inc., Abbott Diabetes Care Inc, Arkal Medical, Inc., Ascensia Diabetes Care Holdings AG, Biorasis Inc, Debiotech SA, DirectSens GmbH, Echo Therapeutics Inc, EyeSense GmbH, Flowsion A/S, GlucoSet AS, Glucovation Inc, Glusense Ltd, GlySens Inc, iGlyko, Inc., Indigo Diabetes NV, Insulet Corp, Integrated Medical Sensors, Integrity Applications Ltd, I-Sens Inc, Metronom Health Inc, Nemaura Medical Inc, PKvitality, Prediktor Medical AS, Profusa Inc, San Meditech (Huzhou) Co., Ltd., Senzime AB, Socrates Health Solutions, Inc., and other prominent players.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Continuous Glucose Monitoring (CGM) Sensors Market Snapshot

Chapter 4. Global Continuous Glucose Monitoring (CGM) Sensors Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Key Trends in the Market

4.8. COVID 19 Impact Analysis

4.9. Pelvic Organ Prolapse Incidence and Prevalence in Key Countries

4.10. Stress Urinary Incontinence Incidence and Prevalence in Key Countries

Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2019 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2016 to 2026 for the following By Products:

5.2.1. Non-invasive Sensing

5.2.2. Minimally Invasive Sensing

Chapter 6. Continuous Glucose Monitoring (CGM) Sensors Market Segmentation 2: By Sensing Technology Estimates & Trend Analysis

6.1. By Sensing Technology Analysis & Market Share, 2019 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2016 to 2026 for the following By Sensing Technology:

6.2.1. Enzyme Electrode

6.2.2. Optical Fluorescence

6.2.3. Others

Chapter 7. Continuous Glucose Monitoring (CGM) Sensors Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By End-Users Analysis & Market Share, 2019 & 2028

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2016 to 2026 for the following By End-Users:

7.2.1. Hospitals and Homecare

7.2.2. Specialty Clinics

7.2.3. Ambulatory Settings

7.2.4. Others

Chapter 8. Continuous Glucose Monitoring (CGM) Sensors Market Segmentation 3: By Demographics Estimates & Trend Analysis

8.1. By Demographics Analysis & Market Share, 2019 & 2028

8.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2016 to 2026 for the following By Demographics:

8.2.1. Child Population

8.2.2. Adult Population

Chapter 9. Continuous Glucose Monitoring (CGM) Sensors Market Segmentation 3: By Sensor Sites Estimates & Trend Analysis

9.1. By Sensor Sites Analysis & Market Share, 2019 & 2028

9.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2016 to 2026 for the following By Sensor Sites:

9.2.1. Abdomen

9.2.2. Upper Arm (implanted)

9.2.3. Back of Upper Arm

9.2.4. Other (Abdomen and Buttocks)

Chapter 10. Continuous Glucose Monitoring (CGM) Sensors Market Segmentation 3: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2019-2028

10.1.2. North America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sensing Technology, 2019-2028

10.1.3. North America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2019-2028

10.1.4. North America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Demographics, 2019-2028

10.1.5. North America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sensor Sites, 2019-2028

10.1.6. North America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2019-2028

10.1.6.1. U.S.

10.1.6.2. Canada

10.2. Europe

10.2.1. Europe Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Products, 2019-2028

10.2.2. Europe Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Sensing Technology, 2019-2028

10.2.3. Europe Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2019-2028

10.2.4. Europe Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Demographics, 2019-2028

10.2.5. Europe Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sensor Sites, 2019-2028

10.2.6. Europe Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) by country, 2019-2028

10.2.6.1. Germany

10.2.6.2. Poland

10.2.6.3. France

10.2.6.4. Italy

10.2.6.5. Spain

10.2.6.6. UK

10.2.6.7. Rest of Europe

10.3. Asia Pacific

10.3.1. Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Products, 2019-2028

10.3.2. Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Sensing Technology, 2019-2028

10.3.3. Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2019-2028

10.3.4. Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Demographics, 2019-2028

10.3.5. Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sensor Sites, 2019-2028

10.3.6. Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) by country, 2019-2028

10.3.6.1. China

10.3.6.2. India

10.3.6.3. Japan

10.3.6.4. Australia

10.3.6.5. Rest of Asia Pacific

10.4. Latin America

10.4.1. Latin America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2019-2028

10.4.2. Latin America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Sensing Technology, (US$ Million) 2019-2028

10.4.3. Latin America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2019-2028

10.4.4. Latin America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Demographics, 2019-2028

10.4.5. Latin America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sensor Sites, 2019-2028

10.4.6. Latin America Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2019-2028

10.4.6.1. Brazil

10.4.6.2. Rest of Latin America

10.5. MEA

10.5.1. MEA revenue Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2019-2028

10.5.2. MEA revenue Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By Sensing Technology, (US$ Million) 2019-2028

10.5.3. MEA revenue Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2019-2028

10.5.4. MEA Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Demographics, 2019-2028

10.5.5. MEA Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sensor Sites, 2019-2028

10.5.6. MEA revenue Continuous Glucose Monitoring (CGM) Sensors Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2019-2028

10.5.6.1. South Africa

10.5.6.2. Rest of MEA

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Medtronics

11.2.2. Abbott

11.2.3. Dexcom

11.2.4. Senseonics

11.2.5. WaveForm Technologies, Inc.

11.2.6. Abbott Diabetes Care Inc

11.2.7. Advanced Biosensors-Ohio LLC

11.2.8. Arkal Medical, Inc.

11.2.9. Ascensia Diabetes Care Holdings AG

11.2.10. Azurite Technologies, Inc.

11.2.11. Biorasis Inc

11.2.12. Biovotion AG

11.2.13. CALISTO MEDICAL, INC.

11.2.14. CGM3 Ltd

11.2.15. ConvaTec Group Plc

11.2.16. Cyber Medical Ltd

11.2.17. Debiotech SA

11.2.18. DexCom Inc

11.2.19. DirectSens GmbH

11.2.20. Echo Therapeutics Inc

11.2.21. Ecole Polytechnique Federale de Lausanne

11.2.22. eLutions Integrated Systems, Inc.

11.2.23. EyeSense GmbH

11.2.24. Flowsion A/S

11.2.25. Gili Medical Ltd

11.2.26. Globe Medical Tech Inc

11.2.27. GlucoLight Corporation

11.2.28. Glucometrix AG

11.2.29. Glucosense Diagnostics Ltd

11.2.30. GlucoSet AS

11.2.31. Glucovation Inc

11.2.32. GluMetrics Inc

11.2.33. Glusense Ltd

11.2.34. GlySens Inc

11.2.35. Glysure Ltd

11.2.36. G-Sense Ltd.

11.2.37. iGlyko, Inc.

11.2.38. Indigo Diabetes NV

11.2.39. Innovosens AB

11.2.40. Insulet Corp

11.2.41. Integrated Medical Sensors

11.2.42. Integrity Applications Ltd

11.2.43. Invivosense ASA

11.2.44. I-Sens Inc

11.2.45. iSense Corporation

11.2.46. Keratin Biosciences Inc

11.2.47. Kiffik Biomedical inc.

11.2.48. LEMM Technologies, LLC

11.2.49. Mellitor Ltd

11.2.50. Metronom Health Inc

11.2.51. mobiLIFE

11.2.52. Nemaura Medical Inc

11.2.53. Newton Photonics Inc

11.2.54. Orsus Medical Ltd

11.2.55. PKvitality

11.2.56. PositiveID Corp

11.2.57. Prediktor Medical AS

11.2.58. Profusa Inc

11.2.59. Purdue University

11.2.60. San Meditech (Huzhou) Co., Ltd.

11.2.61. Senseonics Holdings Inc

11.2.62. SensiVida Medical Technologies, Inc.

11.2.63. Senzime AB

11.2.64. Singapore Biomicro Pte Ltd

11.2.65. Socrates Health Solutions, Inc.

11.2.66. Tenax Therapeutics Inc

11.2.67. VeriTeQ Corporation

11.2.68. Vytrace, Inc.

8.3. List of Other Prominent Players

Global Continuous Glucose Monitoring (CGM) Sensors Market Segmentation:

Global Continuous Glucose Monitoring (CGM) Sensors Market By Products

  • Non-invasive Sensing
  • Minimally Invasive Sensing

Global Continuous Glucose Monitoring (CGM) Sensors Market By Sensing Technology

  • Enzyme Electrode
  • Optical Fluorescence
  • Others

Global Continuous Glucose Monitoring (CGM) Sensors Market By End-Users

  • Hospitals and Home care
  • Specialty Clinics
  • Ambulatory Settings
  • Others

Global Continuous Glucose Monitoring (CGM) Sensors Market By Patient Population

  • Children and Teenagers
  • Adults

Global Continuous Glucose Monitoring (CGM) Sensors Market By Sensor Sites

  • Abdomen
  • Upper Arm (implanted)
  • Back of Upper Arm
  • Other (Abdomen and Buttocks)

Global Continuous Glucose Monitoring (CGM) Sensors Market By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Continuous Glucose Monitoring (CGM) Sensors Market?

The Continuous Glucose Monitoring (CGM) Sensors Market worth $ 11.7 Billion by 2028

CAGR of 18% from 2021 to 2028.

Our Clients

Media Citations

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4182
$10000
$10000
Related Reports
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals
Review Request

We’ll review your request & send a personalized quote for cost and time needed
Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

Category
Quick Links
Office Address